Tumor Growth Rate as a New Predictor of Progression-Free Survival After Chordoma Surgery.

MLA

Passeri, Thibault, et al. “Tumor Growth Rate as a New Predictor of Progression-Free Survival After Chordoma Surgery.” Neurosurgery, vol. 89, no. 2, July 2021, pp. 291–99. EBSCOhost, https://doi.org/10.1093/neuros/nyab164.

APA

Passeri, T., di Russo, P., Champagne, P.-O., Bernat, A.-L., Cartailler, J., Guichard, J. P., Mammar, H., Giammattei, L., Adle-Biassette, H., George, B., Mandonnet, E., & Froelich, S. (2021). Tumor Growth Rate as a New Predictor of Progression-Free Survival After Chordoma Surgery. Neurosurgery, 89(2), 291–299. https://doi.org/10.1093/neuros/nyab164

Chicago

Passeri, Thibault, Paolo di Russo, Pierre-Olivier Champagne, Anne-Laure Bernat, Jérome Cartailler, Jean Pierre Guichard, Hamid Mammar, et al. 2021. “Tumor Growth Rate as a New Predictor of Progression-Free Survival After Chordoma Surgery.” Neurosurgery 89 (2): 291–99. doi:10.1093/neuros/nyab164.